{"id":350955,"date":"2025-08-25T20:19:00","date_gmt":"2025-08-25T20:19:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-alnylam-pharmaceuticals\/"},"modified":"2025-08-25T20:19:00","modified_gmt":"2025-08-25T20:19:00","slug":"how-to-buy-alnylam-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. Kh\u00e1m ph\u00e1 hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i t\u0103ng tr\u01b0\u1edfng cho n\u0103m 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) v\u00e0 \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y. Kh\u00e1m ph\u00e1 hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 c\u01a1 h\u1ed9i t\u0103ng tr\u01b0\u1edfng cho n\u0103m 2025."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a y h\u1ecdc di truy\u1ec1n? Alnylam Pharmaceuticals (ALNY) \u0111ang d\u1eabn \u0111\u1ea7u cu\u1ed9c c\u00e1ch m\u1ea1ng RNAi v\u1edbi n\u0103m lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5. Nh\u00e0 ti\u00ean phong c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y mang \u0111\u1ebfn c\u1ea3 khoa h\u1ecdc ti\u00ean ti\u1ebfn v\u00e0 hi\u1ec7u su\u1ea5t t\u00e0i ch\u00ednh \u1ea5n t\u01b0\u1ee3ng \u2014 ho\u00e0n h\u1ea3o cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm \u0111\u1ed5i m\u1edbi v\u00e0 l\u1ee3i nhu\u1eadn.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ty \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a y h\u1ecdc di truy\u1ec1n? Alnylam Pharmaceuticals (ALNY) \u0111ang d\u1eabn \u0111\u1ea7u cu\u1ed9c c\u00e1ch m\u1ea1ng RNAi v\u1edbi n\u0103m lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 t\u0103ng tr\u01b0\u1edfng doanh thu b\u00f9ng n\u1ed5. Nh\u00e0 ti\u00ean phong c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y mang \u0111\u1ebfn c\u1ea3 khoa h\u1ecdc ti\u00ean ti\u1ebfn v\u00e0 hi\u1ec7u su\u1ea5t t\u00e0i ch\u00ednh \u1ea5n t\u01b0\u1ee3ng \u2014 ho\u00e0n h\u1ea3o cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm \u0111\u1ed5i m\u1edbi v\u00e0 l\u1ee3i nhu\u1eadn."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Alnylam: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Alnylam Pharmaceuticals (ALNY) giao d\u1ecbch \u1edf m\u1ee9c <strong>454,38 USD<\/strong> tr\u00ean NASDAQ. C\u1ed5 phi\u1ebfu g\u1ea7n \u0111\u00e2y \u0111\u00e3 \u0111\u1ea1t m\u1ee9c cao k\u1ef7 l\u1ee5c 467,55 USD v\u00e0o ng\u00e0y 21 th\u00e1ng 8 n\u0103m 2025, th\u1ec3 hi\u1ec7n \u0111\u1ed9ng l\u1ef1c \u0111\u00e1ng kinh ng\u1ea1c.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 30 th\u00e1ng 10 n\u0103m 2025 r\u1ea5t quan tr\u1ecdng.<\/strong> \u0110\u00f3 l\u00e0 khi Alnylam c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ALNY:<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Th\u00e1ng 7, 2025<\/td><td>Thu nh\u1eadp Q2<\/td><td>392,24 USD<\/td><td>+15,9% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 300%)<\/td><\/tr> <tr><td>30 Th\u00e1ng 4, 2025<\/td><td>Thu nh\u1eadp Q1<\/td><td>326,09 USD<\/td><td>+20,3% (t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh)<\/td><\/tr> <tr><td>28 Th\u00e1ng 2, 2025<\/td><td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td><td>304,56 USD<\/td><td>+6,8% (t\u0103ng h\u01b0\u1edbng d\u1eabn)<\/td><\/tr> <tr><td>31 Th\u00e1ng 10, 2024<\/td><td>Thu nh\u1eadp Q3<\/td><td>280,15 USD<\/td><td>+8,7% (ti\u1ebfn tri\u1ec3n trong pipeline)<\/td><\/tr> <tr><td>31 Th\u00e1ng 7, 2024<\/td><td>Thu nh\u1eadp Q2<\/td><td>258,90 USD<\/td><td>+8,2% (ph\u00ea duy\u1ec7t quy \u0111\u1ecbnh)<\/td><\/tr> <tr><td>30 Th\u00e1ng 4, 2024<\/td><td>Thu nh\u1eadp Q1<\/td><td>239,40 USD<\/td><td>+8,1% (m\u1edf r\u1ed9ng th\u01b0\u01a1ng m\u1ea1i)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng:<\/strong> Nh\u1eefng b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 thu nh\u1eadp t\u1ea1o ra c\u00e1c c\u00fa nh\u1ea3y gi\u00e1 l\u1edbn. K\u1ebft qu\u1ea3 v\u01b0\u1ee3t tr\u1ed9i qu\u00fd 2 n\u0103m 2025 \u0111\u00e3 th\u00fac \u0111\u1ea9y t\u0103ng 15,9% ch\u1ec9 trong v\u00e0i tu\u1ea7n. K\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi, nh\u01b0ng ALNY li\u00ean t\u1ee5c ph\u1ee5c h\u1ed3i nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 N\u0103m 2025)<\/h3> <p>C\u1ed5 phi\u1ebfu Alnylam \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn <strong>+199%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p> <ul> <li><strong>Th\u00e1ng 2:<\/strong> ~151 USD (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li> <li><strong>Th\u00e1ng 5:<\/strong> 304,56 USD (v\u01b0\u1ee3t thu nh\u1eadp Q1 v\u00e0 t\u0103ng h\u01b0\u1edbng d\u1eabn)<\/li> <li><strong>Th\u00e1ng 6:<\/strong> 326,09 USD (\u0111\u00e0 ph\u00ea duy\u1ec7t quy \u0111\u1ecbnh)<\/li> <li><strong>Th\u00e1ng 7:<\/strong> 392,24 USD (thu nh\u1eadp Q2 b\u00f9ng n\u1ed5 +64% t\u0103ng tr\u01b0\u1edfng doanh thu)<\/li> <li><strong>Th\u00e1ng 8:<\/strong> 454,38 USD (m\u1ee9c cao k\u1ef7 l\u1ee5c v\u1edbi c\u00e1c ph\u00ea duy\u1ec7t m\u1edf r\u1ed9ng)<\/li> <\/ul> <h3>T\u1ea1i sao t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5?<\/h3> <ul> <li>Doanh thu AMVUTTRA t\u0103ng m\u1ea1nh v\u1edbi ph\u00ea duy\u1ec7t ATTR-CM<\/li> <li>M\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf v\u00e0o EU, UK, Nh\u1eadt B\u1ea3n, Brazil<\/li> <li>Kho\u1ea3ng 1.400 b\u1ec7nh nh\u00e2n \u0111ang \u0111i\u1ec1u tr\u1ecb AMVUTTRA<\/li> <li>T\u0103ng h\u01b0\u1edbng d\u1eabn doanh thu 2025 l\u00ean 2,65-2,8 t\u1ef7 USD<\/li> <\/ul> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: 2025-2030<\/h2> <ul> <li><strong>2025 (Cu\u1ed1i n\u0103m):<\/strong> 480-520 USD (ti\u1ebfp t\u1ee5c th\u1ef1c thi th\u01b0\u01a1ng m\u1ea1i + thu nh\u1eadp Q4) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li> <li><strong>2026:<\/strong> 540-580 USD (d\u1eef li\u1ec7u giai \u0111o\u1ea1n III thu\u1ed1c t\u0103ng huy\u1ebft \u00e1p zilebesiran)<\/li> <li><strong>2028:<\/strong> 650-720 USD (pipeline tr\u01b0\u1edfng th\u00e0nh + ch\u1ec9 \u0111\u1ecbnh m\u1edbi)<\/li> <li><strong>2030:<\/strong> 800+ USD (th\u1ed1ng tr\u1ecb n\u1ec1n t\u1ea3ng RNAi tr\u00ean nhi\u1ec1u b\u1ec7nh)<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn:<\/strong> Tuy\u1ec7t v\u1eddi cho nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n. Ng\u1eafn h\u1ea1n? H\u00e3y theo d\u00f5i c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o thu nh\u1eadp.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3> <ul> <li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd:<\/strong> Quy\u1ebft \u0111\u1ecbnh FDA cho li\u1ec7u ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 b\u1ecb tr\u00ec ho\u00e3n ho\u1eb7c t\u1eeb ch\u1ed1i (<a href=\"https:\/\/monexa.ai\/blog\/alnylam-alny-rnai-therapeutics-earnings-beat-and-r-ALNY-2025-02-25\">Ph\u00e2n t\u00edch R\u1ee7i Ro Ph\u00e1p L\u00fd<\/a>)<\/li> <li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/strong> C\u00e1c \u1ee9ng vi\u00ean pipeline c\u00f3 th\u1ec3 kh\u00f4ng ch\u1ee9ng minh \u0111\u01b0\u1ee3c hi\u1ec7u qu\u1ea3\/an to\u00e0n<\/li> <li><strong>C\u1ea1nh tranh:<\/strong> Th\u1ecb tr\u01b0\u1eddng RNAi ng\u00e0y c\u00e0ng c\u1ea1nh tranh v\u1edbi c\u00e1c n\u1ec1n t\u1ea3ng thay th\u1ebf<\/li> <li><strong>\u00c1p l\u1ef1c gi\u00e1:<\/strong> \u0110\u1ea1o lu\u1eadt Gi\u1ea3m L\u1ea1m Ph\u00e1t v\u00e0 thay \u0111\u1ed5i ch\u00ednh s\u00e1ch y t\u1ebf<\/li> <li><strong>Th\u00e1ch th\u1ee9c ho\u00e0n tr\u1ea3:<\/strong> Gi\u00e1 tr\u1ecb d\u1ef1a tr\u00ean hi\u1ec7u qu\u1ea3 \u0111\u1ed1i m\u1eb7t v\u1edbi c\u00e1c h\u1ec7 th\u1ed1ng y t\u1ebf \u0111a d\u1ea1ng<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3> <ul> <li><strong>B\u00f9ng n\u1ed5 doanh thu:<\/strong> Q2 2025: 672 tri\u1ec7u USD (+64% YoY) v\u1edbi h\u01b0\u1edbng d\u1eabn t\u0103ng l\u00ean 2,65-2,8 t\u1ef7 USD<\/li> <li><strong>Chi\u1ebfn th\u1eafng ph\u00e1p l\u00fd:<\/strong> AMVUTTRA \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t t\u1ea1i EU, UK, Nh\u1eadt B\u1ea3n, Brazil cho ATTR-CM<\/li> <li><strong>\u0110\u00e0 pipeline:<\/strong> Ba th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n III l\u1edbn kh\u1edfi \u0111\u1ed9ng n\u0103m 2025<\/li> <li><strong>T\u0103ng tr\u01b0\u1edfng b\u1ec7nh nh\u00e2n:<\/strong> ~1.400 b\u1ec7nh nh\u00e2n d\u00f9ng AMVUTTRA v\u1edbi c\u01a1 s\u1edf \u0111i\u1ec1u tr\u1ecb m\u1edf r\u1ed9ng<\/li> <li><strong>S\u1ee9c m\u1ea1nh ti\u1ec1n m\u1eb7t:<\/strong> 2,86 t\u1ef7 USD d\u1ef1 tr\u1eef \u0111\u1ea3m b\u1ea3o \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i \u2014 ch\u1ec9 c\u1ea7n 100 USD c\u0169ng c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u<\/li> <li><strong>Trung b\u00ecnh gi\u00e1:<\/strong> \u0110\u1ea7u t\u01b0 \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng ch\u1ecdn th\u1eddi \u0111i\u1ec3m ho\u00e0n h\u1ea3o<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o thu nh\u1eadp:<\/strong> Theo d\u00f5i ALNY quanh ng\u00e0y 30 th\u00e1ng 10 \u0111\u1ec3 t\u00ecm c\u01a1 h\u1ed9i mua<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a kh\u00f4n ngoan:<\/strong> Gi\u1eef t\u1ef7 tr\u1ecdng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc trong kho\u1ea3ng 10-15% t\u1ed5ng danh m\u1ee5c<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc:<\/strong> \"Giao d\u1ecbch ALNY gi\u1ed1ng nh\u01b0 xem kh\u00e1m ph\u00e1 khoa h\u1ecdc di\u1ec5n ra \u2014 \u0111\u00f4i khi b\u1ea1n c\u1ea7n \u0111\u1ec3 th\u00ed nghi\u1ec7m ch\u1ea1y tr\u01b0\u1edbc khi th\u1ea5y k\u1ebft qu\u1ea3!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td><td>Cung c\u1ea5p ID v\u00e0 th\u00f4ng tin t\u00e0i ch\u00ednh (th\u01b0\u1eddng 1-2 ng\u00e0y)<\/td><\/tr> <tr><td>3<\/td><td>N\u1ea1p ti\u1ec1n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng r\u1ee7i ro<\/td><\/tr> <tr><td>4<\/td><td>T\u00ecm ki\u1ebfm \"ALNY\"<\/td><td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>5<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o; tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td><\/tr> <tr><td>6<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 t\u1ed5ng chi ph\u00ed tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td><\/tr> <tr><td>7<\/td><td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c quan tr\u1ecdng v\u00e0 s\u1ef1 ki\u1ec7n tin t\u1ee9c<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> \u2014 Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li> <li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong> \u2014 T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn \u0111\u1ecba ph\u01b0\u01a1ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong> \u2014 \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 ALNY v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li> <li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n ng\u01b0\u1eddi d\u00f9ng<\/strong> \u2014 Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u<\/li> <\/ul> <h2>\ud83c\udf0d Alnylam N\u0103m 2025: Ng\u01b0\u1eddi D\u1eabn \u0110\u1ea7u Cu\u1ed9c C\u00e1ch M\u1ea1ng RNAi<\/h2> <p>Alnylam Pharmaceuticals th\u1ed1ng tr\u1ecb th\u1ecb tr\u01b0\u1eddng li\u1ec7u ph\u00e1p RNAi v\u1edbi n\u0103m lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 pipeline h\u01a1n 20 ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng. C\u00f4ng ty \u0111\u00e3 ti\u00ean phong trong c\u00e1i g\u1ecdi l\u00e0 \"Cu\u1ed9c C\u00e1ch M\u1ea1ng RNAi\" t\u1eeb n\u0103m 2002, chuy\u1ec3n h\u00f3a khoa h\u1ecdc \u0111o\u1ea1t gi\u1ea3i Nobel th\u00e0nh c\u00e1c li\u1ec7u ph\u00e1p thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng.<\/p> <h3>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i:<\/h3> <ul> <li><strong>\u0110\u1ed9ng l\u1ef1c doanh thu:<\/strong> 672 tri\u1ec7u USD Q2 2025 (+64% t\u0103ng tr\u01b0\u1edfng)<\/li> <li><strong>D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t:<\/strong> 2,86 t\u1ef7 USD<\/li> <li><strong>Ph\u1ea1m vi to\u00e0n c\u1ea7u:<\/strong> Thu\u1ed1c c\u00f3 m\u1eb7t t\u1ea1i M\u1ef9, EU, UK, Nh\u1eadt B\u1ea3n, Brazil<\/li> <li><strong>\u0110\u1ed9 s\u00e2u pipeline:<\/strong> &gt;25 ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng v\u00e0o cu\u1ed1i n\u0103m 2025<\/li> <\/ul> <h3>Tr\u1ecdng t\u00e2m \u0111i\u1ec1u tr\u1ecb:<\/h3> <ul> <li>Amyloidosis TTR (AMVUTTRA, ONPATTRO)<\/li> <li>C\u00e1c r\u1ed1i lo\u1ea1n chuy\u1ec3n h\u00f3a hi\u1ebfm (GIVLAARI, OXLUMO)<\/li> <li>B\u1ec7nh tim m\u1ea1ch (zilebesiran \u0111ang ph\u00e1t tri\u1ec3n)<\/li> <li>Th\u1ea7n kinh h\u1ecdc v\u00e0 c\u00e1c b\u1ec7nh ph\u1ed5 bi\u1ebfn kh\u00e1c<\/li> <\/ul> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025:<\/strong> C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Alnylam \u0111\u00e3 ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p RNAi c\u00f3 th\u1ec3 ch\u1ec9 c\u1ea7n d\u00f9ng m\u1ed9t ho\u1eb7c hai li\u1ec1u m\u1ed7i n\u0103m \u2014 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh m\u00e3n t\u00ednh v\u00e0 s\u1ef1 ti\u1ec7n l\u1ee3i cho b\u1ec7nh nh\u00e2n!<\/p> <p>\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin v\u00e0 chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m th\u1ecb tr\u01b0\u1eddng ph\u1ee9c t\u1ea1p th\u00e0nh l\u1eddi khuy\u00ean thi\u1ebft th\u1ef1c cho nh\u00e0 \u0111\u1ea7u t\u01b0 h\u00e0ng ng\u00e0y.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Alnylam: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Alnylam Pharmaceuticals (ALNY) giao d\u1ecbch \u1edf m\u1ee9c <strong>454,38 USD<\/strong> tr\u00ean NASDAQ. C\u1ed5 phi\u1ebfu g\u1ea7n \u0111\u00e2y \u0111\u00e3 \u0111\u1ea1t m\u1ee9c cao k\u1ef7 l\u1ee5c 467,55 USD v\u00e0o ng\u00e0y 21 th\u00e1ng 8 n\u0103m 2025, th\u1ec3 hi\u1ec7n \u0111\u1ed9ng l\u1ef1c \u0111\u00e1ng kinh ng\u1ea1c.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Ng\u00e0y 30 th\u00e1ng 10 n\u0103m 2025 r\u1ea5t quan tr\u1ecdng.<\/strong> \u0110\u00f3 l\u00e0 khi Alnylam c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng l\u00e0m gi\u00e1 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu ALNY:<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Th\u00e1ng 7, 2025<\/td>\n<td>Thu nh\u1eadp Q2<\/td>\n<td>392,24 USD<\/td>\n<td>+15,9% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 300%)<\/td>\n<\/tr>\n<tr>\n<td>30 Th\u00e1ng 4, 2025<\/td>\n<td>Thu nh\u1eadp Q1<\/td>\n<td>326,09 USD<\/td>\n<td>+20,3% (t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh)<\/td>\n<\/tr>\n<tr>\n<td>28 Th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft qu\u1ea3 h\u00e0ng n\u0103m<\/td>\n<td>304,56 USD<\/td>\n<td>+6,8% (t\u0103ng h\u01b0\u1edbng d\u1eabn)<\/td>\n<\/tr>\n<tr>\n<td>31 Th\u00e1ng 10, 2024<\/td>\n<td>Thu nh\u1eadp Q3<\/td>\n<td>280,15 USD<\/td>\n<td>+8,7% (ti\u1ebfn tri\u1ec3n trong pipeline)<\/td>\n<\/tr>\n<tr>\n<td>31 Th\u00e1ng 7, 2024<\/td>\n<td>Thu nh\u1eadp Q2<\/td>\n<td>258,90 USD<\/td>\n<td>+8,2% (ph\u00ea duy\u1ec7t quy \u0111\u1ecbnh)<\/td>\n<\/tr>\n<tr>\n<td>30 Th\u00e1ng 4, 2024<\/td>\n<td>Thu nh\u1eadp Q1<\/td>\n<td>239,40 USD<\/td>\n<td>+8,1% (m\u1edf r\u1ed9ng th\u01b0\u01a1ng m\u1ea1i)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng:<\/strong> Nh\u1eefng b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 thu nh\u1eadp t\u1ea1o ra c\u00e1c c\u00fa nh\u1ea3y gi\u00e1 l\u1edbn. K\u1ebft qu\u1ea3 v\u01b0\u1ee3t tr\u1ed9i qu\u00fd 2 n\u0103m 2025 \u0111\u00e3 th\u00fac \u0111\u1ea9y t\u0103ng 15,9% ch\u1ec9 trong v\u00e0i tu\u1ea7n. K\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi, nh\u01b0ng ALNY li\u00ean t\u1ee5c ph\u1ee5c h\u1ed3i nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 N\u0103m 2025)<\/h3>\n<p>C\u1ed5 phi\u1ebfu Alnylam \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn <strong>+199%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 2:<\/strong> ~151 USD (h\u1ee3p nh\u1ea5t sau k\u1ef3 ngh\u1ec9 l\u1ec5)<\/li>\n<li><strong>Th\u00e1ng 5:<\/strong> 304,56 USD (v\u01b0\u1ee3t thu nh\u1eadp Q1 v\u00e0 t\u0103ng h\u01b0\u1edbng d\u1eabn)<\/li>\n<li><strong>Th\u00e1ng 6:<\/strong> 326,09 USD (\u0111\u00e0 ph\u00ea duy\u1ec7t quy \u0111\u1ecbnh)<\/li>\n<li><strong>Th\u00e1ng 7:<\/strong> 392,24 USD (thu nh\u1eadp Q2 b\u00f9ng n\u1ed5 +64% t\u0103ng tr\u01b0\u1edfng doanh thu)<\/li>\n<li><strong>Th\u00e1ng 8:<\/strong> 454,38 USD (m\u1ee9c cao k\u1ef7 l\u1ee5c v\u1edbi c\u00e1c ph\u00ea duy\u1ec7t m\u1edf r\u1ed9ng)<\/li>\n<\/ul>\n<h3>T\u1ea1i sao t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5?<\/h3>\n<ul>\n<li>Doanh thu AMVUTTRA t\u0103ng m\u1ea1nh v\u1edbi ph\u00ea duy\u1ec7t ATTR-CM<\/li>\n<li>M\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf v\u00e0o EU, UK, Nh\u1eadt B\u1ea3n, Brazil<\/li>\n<li>Kho\u1ea3ng 1.400 b\u1ec7nh nh\u00e2n \u0111ang \u0111i\u1ec1u tr\u1ecb AMVUTTRA<\/li>\n<li>T\u0103ng h\u01b0\u1edbng d\u1eabn doanh thu 2025 l\u00ean 2,65-2,8 t\u1ef7 USD<\/li>\n<\/ul>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: 2025-2030<\/h2>\n<ul>\n<li><strong>2025 (Cu\u1ed1i n\u0103m):<\/strong> 480-520 USD (ti\u1ebfp t\u1ee5c th\u1ef1c thi th\u01b0\u01a1ng m\u1ea1i + thu nh\u1eadp Q4) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li>\n<li><strong>2026:<\/strong> 540-580 USD (d\u1eef li\u1ec7u giai \u0111o\u1ea1n III thu\u1ed1c t\u0103ng huy\u1ebft \u00e1p zilebesiran)<\/li>\n<li><strong>2028:<\/strong> 650-720 USD (pipeline tr\u01b0\u1edfng th\u00e0nh + ch\u1ec9 \u0111\u1ecbnh m\u1edbi)<\/li>\n<li><strong>2030:<\/strong> 800+ USD (th\u1ed1ng tr\u1ecb n\u1ec1n t\u1ea3ng RNAi tr\u00ean nhi\u1ec1u b\u1ec7nh)<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn:<\/strong> Tuy\u1ec7t v\u1eddi cho nh\u00e0 \u0111\u1ea7u t\u01b0 t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n. Ng\u1eafn h\u1ea1n? H\u00e3y theo d\u00f5i c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o thu nh\u1eadp.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro c\u1ea7n c\u00e2n nh\u1eafc:<\/h3>\n<ul>\n<li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd:<\/strong> Quy\u1ebft \u0111\u1ecbnh FDA cho li\u1ec7u ph\u00e1p m\u1edbi c\u00f3 th\u1ec3 b\u1ecb tr\u00ec ho\u00e3n ho\u1eb7c t\u1eeb ch\u1ed1i (<a href=\"https:\/\/monexa.ai\/blog\/alnylam-alny-rnai-therapeutics-earnings-beat-and-r-ALNY-2025-02-25\">Ph\u00e2n t\u00edch R\u1ee7i Ro Ph\u00e1p L\u00fd<\/a>)<\/li>\n<li><strong>Th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/strong> C\u00e1c \u1ee9ng vi\u00ean pipeline c\u00f3 th\u1ec3 kh\u00f4ng ch\u1ee9ng minh \u0111\u01b0\u1ee3c hi\u1ec7u qu\u1ea3\/an to\u00e0n<\/li>\n<li><strong>C\u1ea1nh tranh:<\/strong> Th\u1ecb tr\u01b0\u1eddng RNAi ng\u00e0y c\u00e0ng c\u1ea1nh tranh v\u1edbi c\u00e1c n\u1ec1n t\u1ea3ng thay th\u1ebf<\/li>\n<li><strong>\u00c1p l\u1ef1c gi\u00e1:<\/strong> \u0110\u1ea1o lu\u1eadt Gi\u1ea3m L\u1ea1m Ph\u00e1t v\u00e0 thay \u0111\u1ed5i ch\u00ednh s\u00e1ch y t\u1ebf<\/li>\n<li><strong>Th\u00e1ch th\u1ee9c ho\u00e0n tr\u1ea3:<\/strong> Gi\u00e1 tr\u1ecb d\u1ef1a tr\u00ean hi\u1ec7u qu\u1ea3 \u0111\u1ed1i m\u1eb7t v\u1edbi c\u00e1c h\u1ec7 th\u1ed1ng y t\u1ebf \u0111a d\u1ea1ng<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3>\n<ul>\n<li><strong>B\u00f9ng n\u1ed5 doanh thu:<\/strong> Q2 2025: 672 tri\u1ec7u USD (+64% YoY) v\u1edbi h\u01b0\u1edbng d\u1eabn t\u0103ng l\u00ean 2,65-2,8 t\u1ef7 USD<\/li>\n<li><strong>Chi\u1ebfn th\u1eafng ph\u00e1p l\u00fd:<\/strong> AMVUTTRA \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t t\u1ea1i EU, UK, Nh\u1eadt B\u1ea3n, Brazil cho ATTR-CM<\/li>\n<li><strong>\u0110\u00e0 pipeline:<\/strong> Ba th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n III l\u1edbn kh\u1edfi \u0111\u1ed9ng n\u0103m 2025<\/li>\n<li><strong>T\u0103ng tr\u01b0\u1edfng b\u1ec7nh nh\u00e2n:<\/strong> ~1.400 b\u1ec7nh nh\u00e2n d\u00f9ng AMVUTTRA v\u1edbi c\u01a1 s\u1edf \u0111i\u1ec1u tr\u1ecb m\u1edf r\u1ed9ng<\/li>\n<li><strong>S\u1ee9c m\u1ea1nh ti\u1ec1n m\u1eb7t:<\/strong> 2,86 t\u1ef7 USD d\u1ef1 tr\u1eef \u0111\u1ea3m b\u1ea3o \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf:<\/strong> B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i \u2014 ch\u1ec9 c\u1ea7n 100 USD c\u0169ng c\u00f3 th\u1ec3 b\u1eaft \u0111\u1ea7u<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1:<\/strong> \u0110\u1ea7u t\u01b0 \u0111\u1ec1u \u0111\u1eb7n thay v\u00ec c\u1ed1 g\u1eafng ch\u1ecdn th\u1eddi \u0111i\u1ec3m ho\u00e0n h\u1ea3o<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o thu nh\u1eadp:<\/strong> Theo d\u00f5i ALNY quanh ng\u00e0y 30 th\u00e1ng 10 \u0111\u1ec3 t\u00ecm c\u01a1 h\u1ed9i mua<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a kh\u00f4n ngoan:<\/strong> Gi\u1eef t\u1ef7 tr\u1ecdng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc trong kho\u1ea3ng 10-15% t\u1ed5ng danh m\u1ee5c<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc:<\/strong> &#8220;Giao d\u1ecbch ALNY gi\u1ed1ng nh\u01b0 xem kh\u00e1m ph\u00e1 khoa h\u1ecdc di\u1ec5n ra \u2014 \u0111\u00f4i khi b\u1ea1n c\u1ea7n \u0111\u1ec3 th\u00ed nghi\u1ec7m ch\u1ea1y tr\u01b0\u1edbc khi th\u1ea5y k\u1ebft qu\u1ea3!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>Cung c\u1ea5p ID v\u00e0 th\u00f4ng tin t\u00e0i ch\u00ednh (th\u01b0\u1eddng 1-2 ng\u00e0y)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n s\u1eb5n s\u00e0ng r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;ALNY&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o; tr\u00e1nh l\u1ec7nh th\u1ecb tr\u01b0\u1eddng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng v\u00e0 t\u1ed5ng chi ph\u00ed tr\u01b0\u1edbc khi th\u1ef1c hi\u1ec7n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1 cho c\u00e1c m\u1ee9c quan tr\u1ecdng v\u00e0 s\u1ef1 ki\u1ec7n tin t\u1ee9c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>Pocket Option gi\u00fap \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn cho m\u1ecdi ng\u01b0\u1eddi:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u: 5 USD<\/strong> \u2014 Ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro th\u1ea5p<\/li>\n<li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong> \u2014 T\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n ch\u00ednh ph\u1ee7 n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> \u2014 Ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed, th\u1ebb ng\u00e2n h\u00e0ng v\u00e0 c\u00e1c l\u1ef1a ch\u1ecdn \u0111\u1ecba ph\u01b0\u01a1ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu l\u1ebb c\u00f3 s\u1eb5n<\/strong> \u2014 \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n nh\u01b0 ALNY v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf<\/li>\n<li><strong>N\u1ec1n t\u1ea3ng th\u00e2n thi\u1ec7n ng\u01b0\u1eddi d\u00f9ng<\/strong> \u2014 Giao di\u1ec7n tr\u1ef1c quan thi\u1ebft k\u1ebf cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Alnylam N\u0103m 2025: Ng\u01b0\u1eddi D\u1eabn \u0110\u1ea7u Cu\u1ed9c C\u00e1ch M\u1ea1ng RNAi<\/h2>\n<p>Alnylam Pharmaceuticals th\u1ed1ng tr\u1ecb th\u1ecb tr\u01b0\u1eddng li\u1ec7u ph\u00e1p RNAi v\u1edbi n\u0103m lo\u1ea1i thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t v\u00e0 pipeline h\u01a1n 20 ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng. C\u00f4ng ty \u0111\u00e3 ti\u00ean phong trong c\u00e1i g\u1ecdi l\u00e0 &#8220;Cu\u1ed9c C\u00e1ch M\u1ea1ng RNAi&#8221; t\u1eeb n\u0103m 2002, chuy\u1ec3n h\u00f3a khoa h\u1ecdc \u0111o\u1ea1t gi\u1ea3i Nobel th\u00e0nh c\u00e1c li\u1ec7u ph\u00e1p thay \u0111\u1ed5i cu\u1ed9c s\u1ed1ng.<\/p>\n<h3>V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i:<\/h3>\n<ul>\n<li><strong>\u0110\u1ed9ng l\u1ef1c doanh thu:<\/strong> 672 tri\u1ec7u USD Q2 2025 (+64% t\u0103ng tr\u01b0\u1edfng)<\/li>\n<li><strong>D\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t:<\/strong> 2,86 t\u1ef7 USD<\/li>\n<li><strong>Ph\u1ea1m vi to\u00e0n c\u1ea7u:<\/strong> Thu\u1ed1c c\u00f3 m\u1eb7t t\u1ea1i M\u1ef9, EU, UK, Nh\u1eadt B\u1ea3n, Brazil<\/li>\n<li><strong>\u0110\u1ed9 s\u00e2u pipeline:<\/strong> &gt;25 ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng v\u00e0o cu\u1ed1i n\u0103m 2025<\/li>\n<\/ul>\n<h3>Tr\u1ecdng t\u00e2m \u0111i\u1ec1u tr\u1ecb:<\/h3>\n<ul>\n<li>Amyloidosis TTR (AMVUTTRA, ONPATTRO)<\/li>\n<li>C\u00e1c r\u1ed1i lo\u1ea1n chuy\u1ec3n h\u00f3a hi\u1ebfm (GIVLAARI, OXLUMO)<\/li>\n<li>B\u1ec7nh tim m\u1ea1ch (zilebesiran \u0111ang ph\u00e1t tri\u1ec3n)<\/li>\n<li>Th\u1ea7n kinh h\u1ecdc v\u00e0 c\u00e1c b\u1ec7nh ph\u1ed5 bi\u1ebfn kh\u00e1c<\/li>\n<\/ul>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025:<\/strong> C\u00e1c nh\u00e0 khoa h\u1ecdc c\u1ee7a Alnylam \u0111\u00e3 ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p RNAi c\u00f3 th\u1ec3 ch\u1ec9 c\u1ea7n d\u00f9ng m\u1ed9t ho\u1eb7c hai li\u1ec1u m\u1ed7i n\u0103m \u2014 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh m\u00e3n t\u00ednh v\u00e0 s\u1ef1 ti\u1ec7n l\u1ee3i cho b\u1ec7nh nh\u00e2n!<\/p>\n<p>\u0110\u1ec3 bi\u1ebft th\u00eam th\u00f4ng tin v\u00e0 chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m th\u1ecb tr\u01b0\u1eddng ph\u1ee9c t\u1ea1p th\u00e0nh l\u1eddi khuy\u00ean thi\u1ebft th\u1ef1c cho nh\u00e0 \u0111\u1ea7u t\u01b0 h\u00e0ng ng\u00e0y.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu ALNY?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 ALNY, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"ALNY c\u00f3 r\u1ee7i ro g\u00ec c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA, th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1ea1nh tranh th\u1ecb tr\u01b0\u1eddng RNAi, \u00e1p l\u1ef1c gi\u00e1 v\u00e0 th\u00e1ch th\u1ee9c ho\u00e0n tr\u1ea3 trong h\u1ec7 th\u1ed1ng y t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu ALNY trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 ALNY s\u1ebd t\u0103ng l\u00ean 480-520 USD v\u00e0o cu\u1ed1i n\u0103m 2025, ti\u1ebfp t\u1ee5c t\u0103ng \u0111\u1ebfn 800 USD ho\u1eb7c h\u01a1n v\u00e0o n\u0103m 2030 nh\u1edd s\u1ef1 ph\u00e1t tri\u1ec3n c\u1ee7a n\u1ec1n t\u1ea3ng RNAi."},{"question":"T\u1ea1i sao n\u00ean \u0111\u1ea7u t\u01b0 v\u00e0o Alnylam Pharmaceuticals?","answer":"Alnylam l\u00e0 nh\u00e0 ti\u00ean phong trong li\u1ec7u ph\u00e1p RNAi v\u1edbi nhi\u1ec1u thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh, m\u1edf r\u1ed9ng to\u00e0n c\u1ea7u v\u00e0 pipeline \u0111a d\u1ea1ng, ph\u00f9 h\u1ee3p cho \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n."},{"question":"Pocket Option c\u00f3 l\u1ee3i \u00edch g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu ALNY?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 ALNY, ch\u1ecdn lo\u1ea1i l\u1ec7nh, x\u00e1c nh\u1eadn giao d\u1ecbch v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a b\u1ea1n."},{"question":"ALNY c\u00f3 r\u1ee7i ro g\u00ec c\u1ea7n l\u01b0u \u00fd?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m r\u00e0o c\u1ea3n ph\u00e1p l\u00fd t\u1eeb FDA, th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, c\u1ea1nh tranh th\u1ecb tr\u01b0\u1eddng RNAi, \u00e1p l\u1ef1c gi\u00e1 v\u00e0 th\u00e1ch th\u1ee9c ho\u00e0n tr\u1ea3 trong h\u1ec7 th\u1ed1ng y t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu ALNY trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 ALNY s\u1ebd t\u0103ng l\u00ean 480-520 USD v\u00e0o cu\u1ed1i n\u0103m 2025, ti\u1ebfp t\u1ee5c t\u0103ng \u0111\u1ebfn 800 USD ho\u1eb7c h\u01a1n v\u00e0o n\u0103m 2030 nh\u1edd s\u1ef1 ph\u00e1t tri\u1ec3n c\u1ee7a n\u1ec1n t\u1ea3ng RNAi."},{"question":"T\u1ea1i sao n\u00ean \u0111\u1ea7u t\u01b0 v\u00e0o Alnylam Pharmaceuticals?","answer":"Alnylam l\u00e0 nh\u00e0 ti\u00ean phong trong li\u1ec7u ph\u00e1p RNAi v\u1edbi nhi\u1ec1u thu\u1ed1c \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t, t\u0103ng tr\u01b0\u1edfng doanh thu m\u1ea1nh, m\u1edf r\u1ed9ng to\u00e0n c\u1ea7u v\u00e0 pipeline \u0111a d\u1ea1ng, ph\u00f9 h\u1ee3p cho \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n."},{"question":"Pocket Option c\u00f3 l\u1ee3i \u00edch g\u00ec cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p ti\u1ec1n t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, h\u1ed7 tr\u1ee3 c\u1ed5 phi\u1ebfu l\u1ebb v\u00e0 giao di\u1ec7n th\u00e2n thi\u1ec7n, r\u1ea5t ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T20:19:00+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)\",\"datePublished\":\"2025-08-25T20:19:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-25T20:19:00+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T20:19:00+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","datePublished":"2025-08-25T20:19:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-25T20:19:00+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Alnylam Pharmaceuticals, Inc. (ALNY)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":350952,"slug":"how-to-buy-alnylam-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Alnylam Pharmaceuticals, Inc. (ALNY) - Investimento em a\u00e7\u00f5es da Alnylam Pharmaceuticals, Inc. (ALNY)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-alnylam-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=350955"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/350955\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=350955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=350955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=350955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}